Our findings indicate that the characteristic hyperandrogenism and metabolic dysfunction in PCOS may lead to elevated lipid levels through the upregulation of intestinal SURF4, underscoring its potential as a regulatory factor in the pathogenesis of PCOS-associated dyslipidaemia. This evidence concerns the gene SURF4 and hyperandrogenism.